These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16274406

  • 1. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study.
    Carboni I, de Felice C, Bergamin A, Chimenti S.
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():11-3. PubMed ID: 16274406
    [Abstract] [Full Text] [Related]

  • 2. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM.
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [Abstract] [Full Text] [Related]

  • 3. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L.
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [Abstract] [Full Text] [Related]

  • 5. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M, Mrowietz U, Koenig M, Simon JC.
    Eur J Dermatol; 2003 Aug; 13(3):261-5. PubMed ID: 12804986
    [Abstract] [Full Text] [Related]

  • 6. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
    Langner A, Ashton P, Van De Kerkhof PC, Verjans H.
    Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
    [Abstract] [Full Text] [Related]

  • 7. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH, Chiu HC, Tseng YS, Tsai TF.
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [Abstract] [Full Text] [Related]

  • 8. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
    Miyachi Y, Ohkawara A, Ohkido M, Harada S, Tamaki K, Nakagawa H, Hori Y, Nishiyama S.
    Eur J Dermatol; 2002 Nov; 12(5):463-8. PubMed ID: 12370136
    [Abstract] [Full Text] [Related]

  • 9. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M, Mirada A, López S, Artés M, T.O.P. Research Group.
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 11. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis.
    Marty JP, Lafforgue C, Grossiord JL, Soto P.
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405
    [Abstract] [Full Text] [Related]

  • 12. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [Abstract] [Full Text] [Related]

  • 13. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
    Katayama I, Ohkawara A, Ohkido M, Harada S, Tamaki K, Nakagawa H, Hori Y, Nishiyama S.
    Eur J Dermatol; 2002 Oct; 12(6):553-7. PubMed ID: 12459526
    [Abstract] [Full Text] [Related]

  • 14. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W.
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [Abstract] [Full Text] [Related]

  • 15. 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study.
    Ortonne JP, van de Kerkhof PC, Prinz JC, Bieber T, Lahfa M, Rubins A, Wozel G, Lorette G, European Tacrolimus Psoriasis Study Group.
    Acta Derm Venereol; 2006 Aug; 86(1):29-33. PubMed ID: 16585986
    [Abstract] [Full Text] [Related]

  • 16. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis.
    Lebwohl M, Ortonne JP, Andres P, Briantais P.
    Cutis; 2009 Apr; 83(4):205-12. PubMed ID: 19445311
    [Abstract] [Full Text] [Related]

  • 17. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Apr; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 18. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.